CANNAPHARMARX, INC. (CPMD) Insider Trading Disclosures
CANNAPHARMARX, INC. (CPMD) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CPMD
CIK: 1081938
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Barzily&Co Certified Public Accountants
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerHillel Steinberger
Audit LocationJerusalem, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-18 | 2026-06-30 | FORM 10-Q FOR JUN 2026 | 0001683168-26-006570 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-17 | 2026-06-30 | NT 10-Q | 0001683168-26-006523 | View SEC Doc Filr Page |
| 10-Q | 2026-05-20 | 2026-03-31 | FORM 10-Q | 0001654954-26-005180 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-18 | 2026-03-31 | NT 10-Q | 0001654954-26-005066 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | FORM 10-K | 0001654954-26-003108 | View SEC Doc Filr Page |
| 8-K | 2026-01-13 | 2026-01-08 | FORM 8-K | 0001654954-26-000277 | View SEC Doc Filr Page |
| 8-K | 2025-12-18 | 2025-12-12 | FORM 8-K | 0001654954-25-014070 | View SEC Doc Filr Page |
| 10-Q | 2025-11-14 | 2025-09-30 | FORM 10-Q | 0001654954-25-013083 | View SEC Doc Filr Page |
| 8-K | 2025-10-10 | 2025-08-07 | FORM 8-K | 0001654954-25-011655 | View SEC Doc Filr Page |
| 144 | 2025-08-22 | — | 144 Filing | 0002054793-25-000002 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | FORM 10-Q | 0001654954-25-009626 | View SEC Doc Filr Page |
| 144 | 2025-05-22 | — | 144 Filing | 0002054793-25-000001 | View SEC Doc Filr Page |
| 10-Q | 2025-05-16 | 2025-03-31 | FORM 10-Q | 0001654954-25-005808 | View SEC Doc Filr Page |
| NT 10-Q | 2025-05-16 | 2025-03-31 | NT 10-Q | 0001654954-25-005804 | View SEC Doc Filr Page |
| 8-K | 2025-05-06 | 2025-05-06 | FORM 8-K | 0001654954-25-005135 | View SEC Doc Filr Page |
| 3 | 2025-04-10 | 2025-03-31 | 3 Filing | 0001213900-25-030783 | View SEC Doc Filr Page |
| 3 | 2025-04-10 | 2025-03-31 | 3 Filing | 0001213900-25-030782 | View SEC Doc Filr Page |
| 10-K | 2025-04-10 | 2024-12-31 | FORM 10-K | 0001654954-25-004122 | View SEC Doc Filr Page |
| NT 10-K | 2025-04-01 | 2024-12-31 | NT 10-K | 0001654954-25-003787 | View SEC Doc Filr Page |
| 8-K | 2025-03-31 | 2025-03-26 | FORM 8-K | 0001654954-25-003608 | View SEC Doc Filr Page |
| 8-K | 2024-12-03 | 2024-11-29 | FORM 8-K | 0001654954-24-015107 | View SEC Doc Filr Page |
| 8-K | 2024-11-21 | 2024-11-20 | FORM 8-K | 0001654954-24-014753 | View SEC Doc Filr Page |
| 10-Q | 2024-11-14 | 2024-09-30 | FORM 10-Q | 0001654954-24-014287 | View SEC Doc Filr Page |
| 8-K | 2024-09-17 | 2024-09-09 | CURRENT REPORT | 0001683168-24-006456 | View SEC Doc Filr Page |
| 10-Q | 2024-08-14 | 2024-06-30 | FORM 10-Q FOR JUNE 2024 | 0001683168-24-005699 | View SEC Doc Filr Page |